Evidence map›Paper›PMID 38294883›Full record

ArticleACS applied materials & interfaces2024

Preventing

Adam Hansson, Eskil André Karlsen, Wenche Stensen, John S M Svendsen, Mattias Berglin, Anders Lundgren

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Antifouling Efficacy onACS applied bio materials · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Adam HanssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg 40530, Sweden.
Eskil André KarlsenAmicoat A/S, Sykehusvegen 23, Tromsø 9019, Norway.
Wenche StensenDepartment of Chemistry, UiT The Arctic University of Norway, Tromsø 9037, Norway.
John S M SvendsenAmicoat A/S, Sykehusvegen 23, Tromsø 9019, Norway.ORCID 0000-0001-5945-6123
Mattias BerglinDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg 40530, Sweden.ORCID 0000-0002-9377-8924
Anders LundgrenDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg 40530, Sweden.ORCID 0000-0002-8537-9974
UiT The Arctic University of Norway · NORISE Research Institutes of Sweden · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) can kill bacteria by destabilizing their membranes, yet translating these molecules' properties into a covalently attached antibacterial coating is challenging. Rational design efforts are obstructed by the fact that standard microbiology methods are ill-designed for the evaluation of coatings, disclosing few details about why grafted AMPs function or do not function. It is particularly difficult to distinguish the influence of the AMP's molecular structure from other factors controlling the total exposure, including which type of bonds are formed between bacteria and the coating and how persistent these contacts are. Here, we combine label-free live-cell microscopy, microfluidics, and automated image analysis to study the response of surface-bound

Indexed as

Antimicrobial PeptidesEscherichia coliAnti-Bacterial AgentsBacteriaBiofilmsCoated Materials, BiocompatibleMicroscopyAnti-Bacterial AgentsAntimicrobial PeptidesCoated Materials, Biocompatibleantibiotics resistanceantimicrobial peptidesbiofilmsfimbriaeimage analysislive-cell microscopymicrofluidicssurface coatings

Identifiers

PMID38294883
PMCPMC10875647
OpenAlexW4391384170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.